Asbestos surface provides a niche for oxidative modification

Cancer Science

Volumn 102, Issue 12, 2011, Pages 2118-2125

  Nagai, Hirotaka ^a,b   Ishihara, Toshikazu ^a   Lee, Wen Hua ^b   Ohara, Hiroki ^a   Okazaki, Yasumasa ^a   Okawa, Katsuya ^b   Toyokuni, Shinya ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; AMOSITE; ASBESTOS; CHRYSOTILE; CROCIDOLITE; CYTOSKELETON PROTEIN; HEMOGLOBIN; HISTONE; IRON; NUCLEOTIDE; RIBOSOME PROTEIN; RNA BINDING PROTEIN;

ADSORPTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CARCINOGENICITY; CATALYSIS; CELL LYSATE; CHROMATIN; CONTROLLED STUDY; DISEASE COURSE; DNA DAMAGE; HEMOLYSIS; INTERNALIZATION; LUNG CANCER; LUNG CARCINOGENESIS; MALIGNANT MESOTHELIOMA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MESOTHELIUM CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SURFACE PROPERTY;

ALDEHYDES; ANIMALS; ASBESTOS, AMOSITE; ASBESTOS, CROCIDOLITE; ASBESTOS, SERPENTINE; CHROMATIN; CYTOSKELETON; DEOXYGUANOSINE; DNA; DNA DAMAGE; HEMOGLOBINS; HISTONES; IRON; LUNG NEOPLASMS; MESOTHELIOMA; MICE; OXIDATION-REDUCTION; PROTEINS; RATS; RIBOSOMAL PROTEINS; RNA-BINDING PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SURFACE PROPERTIES;

EID: 81855194114     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02087.x     Document Type: Article

References (69)

1. Berry G. Models for mesothelioma incidence following exposure to fibers in terms of timing and duration of exposure and the biopersistence of the fibers. Inhal Toxicol 1999; 11: 111-30.
2. Pass HI, Vogelzang NJ, Carbone M, eds. Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies. New York, NY: Springer Science+Business Media Inc., 2005.
3. Roggli VL, Oury TD, Sporn TA, eds. Pathology of Asbestos-Associated Diseases. New York: Springer Verlag, 2004.
4. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005; 353: 1591-603.
5. Sekido Y. Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells. Cancer Sci 2010; 101: 1-6.
6. Nagai H, Toyokuni S. Biopersistent fiber-induced inflammation and carcinogenesis: lessons learned from asbestos toward safety of fibrous nanomaterials. Arch Biochem Biophys 2010; 502: 1-7.
7. Toyokuni S. Mechanisms of asbestos-induced carcinogenesis. Nagoya J Med Sci 2009; 71: 1-10.
8. Kamp DW, Graceffa P, Pryor WA, Weitzman SA. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med 1992; 12: 293-315.
9. Maples KR, Johnson NF. Fiber-induced hydroxyl radical formation: correlation with mesothelioma induction in rats and humans. Carcinogenesis 1992; 13: 2035-9.
10. Mossman BT, Marsh JP, Sesko A et al. Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Respir Dis 1990; 141: 1266-71.
11. Vallyathan V, Shi X. The role of oxygen free radicals in occupational and environmental lung diseases. Environ Health Perspect 1997; 105(Suppl. 1): 165-77.
12. Weitzman SA, Graceffa P. Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide. Arch Biochem Biophys 1984; 228: 373-6.
13. Donaldson K, Murphy FA, Duffin R, Poland CA. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2010; 7: 5.
14. Donaldson K, Brown GM, Brown DM, Bolton RE, Davis JM. Inflammation generating potential of long and short fibre amosite asbestos samples. Br J Ind Med 1989; 46: 271-6.
15. Harington JS. Chemical studies of asbestos. Ann N Y Acad Sci 1965; 132: 31-47.
16. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 1996; 20: 553-66.
17. Toyokuni S. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci 2009; 100: 9-16.
18. Chao CC, Park SH, Aust AE. Participation of nitric oxide and iron in the oxidation of DNA in asbestos-treated human lung epithelial cells. Arch Biochem Biophys 1996; 326: 152-7.
19. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997; 387: 147-63.
20. Takeuchi T, Morimoto K. Crocidolite asbestos increased 8-hydroxydeoxyguanosine levels in cellular DNA of a human promyelocytic leukemia cell line, HL60. Carcinogenesis 1994; 15: 635-9.
21. Xu A, Wu LJ, Santella RM, Hei TK. Role of oxyradicals in mutagenicity and DNA damage induced by crocidolite asbestos in mammalian cells. Cancer Res 1999; 59: 5922-6.
22. Harman D. The aging process. Proc Natl Acad Sci USA 1981; 78: 7124-8.
23. Kuchino Y, Mori F, Kasai H et al. Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature 1987; 327: 77-9.
24. Shibutani S, Takeshita M, Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 1991; 349: 431-4.
25. Poser I, Rahman Q, Lohani M et al. Modulation of genotoxic effects in asbestos-exposed primary human mesothelial cells by radical scavengers, metal chelators and a glutathione precursor. Mutat Res 2004; 559: 19-27.
26. Ault JG, Cole RW, Jensen CG, Jensen LC, Bachert LA, Rieder CL. Behavior of crocidolite asbestos during mitosis in living vertebrate lung epithelial cells. Cancer Res 1995; 55: 792-8.
27. Barrett JC, Lamb PW, Wiseman RW. Multiple mechanisms for the carcinogenic effects of asbestos and other mineral fibers. Environ Health Perspect 1989; 81: 81-9.
28. Dopp E, Saedler J, Stopper H, Weiss DG, Schiffmann D. Mitotic disturbances and micronucleus induction in Syrian hamster embryo fibroblast cells caused by asbestos fibers. Environ Health Perspect 1995; 103: 268-71.
29. Dopp E, Schiffmann D. Analysis of chromosomal alterations induced by asbestos and ceramic fibers. Toxicol Lett 1998; 97: 155-62.
30. Hesterberg TW, Barrett JC. Induction by asbestos fibers of anaphase abnormalities: mechanism for aneuploidy induction and possibly carcinogenesis. Carcinogenesis 1985; 6: 473-5.
31. Oshimura M, Hesterberg TW, Barrett JC. An early, nonrandom karyotypic change in immortal Syrian hamster cell lines transformed by asbestos: trisomy of chromosome 11. Cancer Genet Cytogenet 1986; 22: 225-37.
32. DiPaolo JA, DeMarinis AJ, Doniger J. Asbestos and benzo(a)pyrene synergism in the transformation of Syrian hamster embryo cells. Pharmacology 1983; 27: 65-73.
33. Lakowicz JR, Hylden JL. Asbestos-mediated membrane uptake of benzo[a]pyrene observed by fluorescence spectroscopy. Nature 1978; 275: 446-8.
34. 3H]thymidine in hamster tracheal epithelium. Carcinogenesis 1984; 5: 1401-4.
35. Boylan AM, Sanan DA, Sheppard D, Broaddus VC. Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5. J Clin Invest 1995; 96: 1987-2001.
36. Liu W, Ernst JD, Broaddus VC. Phagocytosis of crocidolite asbestos induces oxidative stress, DNA damage, and apoptosis in mesothelial cells. Am J Respir Cell Mol Biol 2000; 23: 371-8.
37. MacCorkle RA, Slattery SD, Nash DR, Brinkley BR. Intracellular protein binding to asbestos induces aneuploidy in human lung fibroblasts. Cell Motil Cytoskeleton 2006; 63: 646-57.
38. Blount M, Holt PF, Leach AA. The protein coating of asbestos bodies. Biochem J 1966; 101: 204-7.
39. Davis JM. Further observations on the ultrastructure and chemistry of the formation of asbestos bodies. Exp Mol Pathol 1970; 13: 346-58.
40. Davis JM. Asbestos dust as a nucleation center in the calcification of old fibrous tissue lesions, and the possible association of this process to the formation of asbestos bodies. Exp Mol Pathol 1970; 12: 133-47.
41. Davis JM, Gross P, De Treville RT. "Ferruginous bodies" in guinea pigs. Fine structure produced experimentally from minerals other than asbestos. Arch Pathol 1970; 89: 364-73.
42. Governa M, Amati M, Fontana S et al. Role of iron in asbestos-body-induced oxidant radical generation. J Toxicol Environ Health A 1999; 58: 279-87.
43. Governa M, Rosanda C. A histochemical study of the asbestos body coating. Br J Ind Med 1972; 29: 154-9.
44. Governa M, Rosanda Vadala C. Histochemical study of asbestos fibre coating in experimental carrageenin granulomas. Br J Ind Med 1973; 30: 248-52.
45. Koerten HK, de Bruijn JD, Daems WT. The formation of asbestos bodies by mouse peritoneal macrophages. An in vitro study. Am J Pathol 1990; 137: 121-34.
46. Koerten HK, Hazekamp J, Kroon M, Daems WT. Asbestos body formation and iron accumulation in mouse peritoneal granulomas after the introduction of crocidolite asbestos fibers. Am J Pathol 1990; 136: 141-57.
47. Langer AM, Rubin IB, Selikoff IJ. Chemical characterization of asbestos body cores by electron microprobe analysis. J Histochem Cytochem 1972; 20: 723-34.
48. Suzuki Y, Churg J. Structure and development of the asbestos body. Am J Pathol 1969; 55: 79-107.
49. Suzuki Y, Churg J. Formation of the asbestos body. A comparative study with three types of asbestos. Environ Res 1970; 3: 107-18.
50. Governa M, Vadala CR. Histochemical demonstration of hematoidin in the innermost layers of human asbestos body coating. Int Arch Arbeitsmed 1972; 30: 273-82.
51. Fubini B, Barcelo F, Otero Arean C. Ferritin adsorption on amosite fibers: possible implications in the formation and toxicity of asbestos bodies. J Toxicol Environ Health 1997; 52: 343-52.
52. Pooley FD. Asbestos bodies, their formation, composition and character. Environ Res 1972; 5: 363-79.
53. O'Connell M, Halliwell B, Moorhouse CP, Aruoma OI, Baum H, Peters TJ. Formation of hydroxyl radicals in the presence of ferritin and haemosiderin. Is haemosiderin formation a biological protective mechanism? Biochem J 1986; 234: 727-31.
54. O'Connell MJ, Ward RJ, Baum H, Peters TJ. Iron release from haemosiderin and ferritin by therapeutic and physiological chelators. Biochem J 1989; 260: 903-7.
55. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-7.
56. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883-99.
57. Yang H, Bocchetta M, Kroczynska B et al. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci USA 2006; 103: 10397-402.
58. Dutta KK, Nishinaka Y, Masutani H et al. Two distinct mechanisms for loss of thioredoxin-binding protein-2 in oxidative stress-induced renal carcinogenesis. Lab Invest 2005; 85: 798-807.
59. Gutteridge JM, Rowley DA, Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of 'free' iron in biological systems by using bleomycin-dependent degradation of DNA. Biochem J 1981; 199: 263-5.
60. Jensen ON, Podtelejnikov A, Mann M. Delayed extraction improves specificity in database searches by matrix-assisted laser desorption/ionization peptide maps. Rapid Commun Mass Spectrom 1996; 10: 1371-8.
61. Jiang L, Nagai H, Ohara H et al. Characteristics and modifying factors of asbestos-induced oxidative DNA damage. Cancer Sci 2008; 99: 2142-51.
62. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 2003; 42: 318-43.
63. Toyokuni S, Kawaguchi W, Akatsuka S, Hiroyasu M, Hiai H. Intermittent microwave irradiation facilitates antigen-antibody reaction in Western blot analysis. Pathol Int 2003; 53: 259-61.
64. Toyokuni S, Miyake N, Hiai H et al. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett 1995; 359: 189-91.
65. Macnab G, Harington JS. Haemolytic activity of asbestos and other mineral dusts. Nature 1967; 214: 522-3.
66. Toyokuni S, Tanaka T, Hattori Y et al. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997; 76: 365-74.
67. 2 accumulation for cell signaling. Cell 2010; 140: 517-28.
68. Nagatomo H, Morimoto Y, Ogami A et al. Change of heme oxygenase-1 expression in lung injury induced by chrysotile asbestos in vivo and in vitro. Inhal Toxicol 2007; 19: 317-23.
69. Nagatomo H, Morimoto Y, Oyabu T et al. Expression of heme oxygenase-1 in the lungs of rats exposed to crocidolite asbestos. Inhal Toxicol 2005; 17: 293-6.